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Abstract 
Many studies indicate that up-regulated production 
of 1,25(0H)rvitamin D3 (calcitriol) with increased in-
testinal absorption of calcium is the primary event caus-
ing idiopathic hypercalciuria. Thus, a low calcium diet 
appears to be a straightforward strategy in calcium stone 
formers withhypercalciuria (HCSF). However, the effi-
cacy of such a regimen has never been established, and 
lowering calcium intake from 1000 to 400 mg/day fur-
ther enhances calcitriol production. On a diet chronical-
ly restricted in calcium, many stone formers increase 
their intake of animal flesh protein. The latter is known 
to increase renal mass, and calcitriol levels indeed are 
positively correlated with renal mass in animals as well 
as in HCSF. Thus, low calcium and high animal flesh 
protein consumption are independent stimuli for further 
up-regulation of calcitriol production. The rise in cal-
citriol suppresses parathyroid hormone synthesis 
thereby diminishing renal tubular calcium reabsorption, 
and increasing urinary calcium losses. Since calcitriol 
up-regulation also increases bone resorption, the combi-
nation of low calcium and high protein intake is particu-
larly likely to induce negative calcium balance and thus 
osteopenia. Finally, low calcium intake carries the risk 
of insufficient intestinal binding of oxalate with subse-
quent increases in intestinal absorption and urinary 
excretion of oxalate. Indeed, most recent studies sug-
gest that high amounts of calcium, when ingested simul-
taneously with oxalate-containing meals, are able to 
prevent hyperoxaluria during severe oral oxalate loading. 
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Introduction 
Already in 1939, Flocks [20] wrote that, "although 
the high concentration of the calcium in the urine of 
itself is not enough to bring about precipitation in the 
kidney substance or in the urinary passageway," hyper-
calciuria might predispose people to form kidney stones. 
More than half a century later, we still are quite uncer-
tain about the pathophysiologic relevance of hypercalci-
uria in nephrolithiasis: in his latest review, Breslau [9] 
only stated that "hypercalciuria could cause or contribute 
to calcium stone formation . " The following discussion 
is focused on the pathophysiology of hypercalciuria and 
hyperoxaluria as well as on the question of whether 
these abnormalities directly cause calcium oxalate stone 
disease, or whether they are rather associated with other 
underlying defects that induce stone formation . 
Physico-Chemical Considerations 
Particle formation within the urinary tract is ulti-
mately driven by increased urinary supersaturation with 
respect to stone forming salts on one hand and, probably 
more important, by an abnormally increased tendency to 
form large crystal aggregates in stone formers on the 
other hand [29] . As elegantly pointed out by Robertson 
et al. [49], the volume of calcium oxalate crystals pre-
cipitated from freshly voided urines of stone formers ex-
ponentially increases with rising concentrations of urina-
ry oxalate, but is largely independent of urinary calcium. 
This is due to the fact that calcium is always present in 
urine in excess over oxalate so that, due to the formation 
of soluble complexes, increases in ionized calcium are 
almost entirely offset by proportional decreases in ion-
ized oxalate [ 49]. On the other hand, rises in urinary 
oxalate in the presence of constant calcium concentra-
tions immediately are followed by increased precipitation 
of calcium oxalate crystals [49]. 
Clinically, these findings are highly relevant in that 
slight increases in urinary oxalate are much more impor-
tant for calcium renal stone formation than respective 
rises in urinary calcium [ 49]. Indeed, it has been known 
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for many years that the severity of stone disease does 
not correlate with daily urinary calcium excretion [19], 
but strongly depends on oxalate excretion rates [47] . 
Nevertheless, urinary calcium has attracted considerably 
more interest by those involved in stone research than 
urinary oxalate, probably for two very simple reasons: 
an overwhelming 80 % of renal stones consist of calcium 
salts, and until recently, measurements of calcium in 
urine have been much easier to perform than measure-
ments of oxalate [6] . 
Idiopathic Hypercalciuria 
Idiopathic hypercalciuria (IH) is a syndrome charac-
terized by normocalcemia, a low serum phosphorus level 
and increased urinary calcium excretion [2] which can-
not be explained by clearly established causes of hyper-
calciuria such as primary hyperparathyroidism, sarcoido-
sis, excessive vitamin D intake, hypercalciuria due to 
hypercalcemia of malignancy or immobilization, medul-
lary sponge kidneys or renal tubular acidosis [28]. Idio-
pathic hypercalciuria can be found in more than half of 
all patients with calcium nephrolithiasis [15] and in 
about 5-10% of normal people [38] . 
Many studies have attempted to distinguish between 
primary "absorptive" and primary "renal" types of IH 
[reviewed in 28] . Already in 1968, Liberman et al. [41] 
concluded "that the primary disturbance in idiopathic 
hypercalciuria is neither intestinal hyperabsorption nor 
urinary hyperexcretion of calcium, but both these ... , 
leading to a high calcium turnover, possibly due to some 
as yet unknown hormonal imbalance." This perfectly 
anticipated forthcoming studies on the pathophysiology 
of IH. Indeed, a substantial body of evidence supports 
the view that "absorptive" and "renal" hypercalciuria are 
not distinct entities, but rather two extremes of a contin-
uum behaviour [13, 14]. However, many studies [re-
viewed in 28] indicate that an increase in intestinal ab-
sorption of calcium is the primary event, either because 
calcitriol production is up-regulated, or, in patients with 
IH in whom serum calcitriol concentrations are not ele-
vated, due to an increased sensitivity of the intestine and 
the parathyroid glands to calcitriol. 
Accelerated intestinal calcium transport and the 
kidneys 
Already in 1958, Henneman et al. [26] presented 
evidence that increased intestinal absorption of calcium 
was the backbone of IH. This was later confirmed by 
others [5, 41, 62] and further supported by several 
studies demonstrating, for reasons not yet fully eluci-
dated, that patients with IH exhibit increased or high-
normal serum levels of 1,25(OH)i-vitaminD3 (calcitriol) 
which are clearly up-regulated in the face of the con-
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centrations of the main modulators of calcitriol, namely 
blood ionized calcium, phosphate and parathyroid hor-
mone (PTH) [reviewed in 28] . Alternatively, an in-
creased number of calcitriol receptors might be present 
[9]. Thus, a low-calcium diet appeared to be a straight-
forward strategy. However, no prospective trial has 
ever established the efficacy of such a regimen with 
respect to stone recurrence [39] . 
The consequences of a low calcium diet have been 
studied in healthy controls as well as in patients with IH: 
in healthy subjects, dietary calcium deprivation induces 
a significant rise in serum calcitriol levels within 48 
hours [1]. In patients with 1H and nephrolithiasis, low-
ering calcium intake from 1000 mg/day to 400 mg/day 
more pronouncedly enhances calcitriol production than 
in normocalciuric stone formers, and serum calcitriol 
levels are abnormally high in the majority of patients 
with IR [10]. Thus, a low calcium diet appears to addi-
tionally amplify what has been recognized as the primary 
defect in IH, i.e., abnormally up-regulated production of 
calcitriol. 
Since stone formers, when given the advice of a low 
calcium diet, have to get their protein from other 
sources than dairy products, they usually increase their 
intake of animal flesh protein (meat, fish, poultry). 
Indeed, overconsumption of animal flesh protein has 
long been recognized as a major risk factor for IH [24, 
46]. Chronic overconsumption of meat protein is also 
known to increase glomerular filtration rate and renal 
size, an effect which is usually more pronounced in ani-
mals than in humans [8, 37] . Nevertheless, striking 
increases in renal size have been described in patients 
receiving large amounts of amino acids during intra-
venous (i .v.) hyperalimentation [12]. Animal studies 
have demonstrated that calcitriol production rates are 
strongly and positively related to renal mass [51], i.e., 
larger kidneys produce more a-hydroxylase and thus 
more calcitriol. 
Accordingly, we recently demonstrated that male 
calcium stone formers with IH had larger kidneys than 
their normocalciuric counterparts, and that renal mass 
directly correlated with urinary phosphate excretion rates 
as a marker of daily protein consumption in the steady 
state [33]. Furthermore, serum calcitriol levels were 
positively correlated with renal mass, suggesting that 
overconsumption of animal flesh protein, by means of an 
increase in renal mass, may be yet another stimulus for 
up-regulation of calcitriol production in 1H [33]. In 
summary, the already increased calcitriol activity in 
many calcium stone formers with IH may additionally be 
up-regulated by dietary calcium restriction and high in-
take of animal flesh protein, as depicted in Figure 1. 
The observed rise in calcitriol activity, however, is 
expected to down-regulatePI'H activity (Fig. 1): on one 
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Figure 1. Three-fold stimulus for increased calcitriol activity in patients with idiopathic hypercalciuria on a low 
calcium/high animal flesh protein diet (meat, fish, poultry) , inducing down-regulation of PTH synthesis. For details, 
see text. 
hand, increases in calcitriol decrease the transcription of 
the PTH gene [54]; on the other hand, the calcitriol-me-
diated rise in intestinal calcium absorption induces steep-
er transient increases in blood ionized calcium after 
meals and thereby produces, repeatedly, another stimu-
lus for down-regulating PTH secretion in HCSF [34]. 
Indeed, in comparison with their normocalciuric counter-
parts, hypercalciuric calcium renal stone formers studied 
on their individual homeostasis (free-choice diet) exhibit 
an imbalance between calcitriol and PTH activities with 
relative hypoparathyroidism [31, 34] . The latter in-
duces a decrease in renal tubular reabsorption of calcium 
and thereby contributes to increased excretion of a given 
daily load of calcium. 
Accelerated calcium transport: bone 
Besides its effects at intestinal and renal levels, up-
regulation in .:alcitriol synthesis also affects calcium 
transport in bone, i.e., bone resorption is increased in 
patients with 1H [41). When healthy volunteers, on a 
low calcium diet (4 mM/day), were given calcitriol, uri-
nary calcium excretion by far exceeded intestinal calci-
um absorption and thus produced negative calcium bal-
ance; this was not the case when calcitriol was adminis-
tered to the same subjects consuming 22 mM calcium 
per day [42). Therefore, the combination of calcitriol 
excess and low calcium intake produces two essential 
features of IH, i.e., absorptive hypercalciuria and bone 
mineral loss [13, 38). 
549 
Moreover, the combination of a low calcium, high 
animal flesh protein diet appears particularly likely to 
induce a negative calcium balance and a loss of bone 
mineral, at least when applied for several days or weeks 
[reviewed in 24) . In calcium renal stone formers, an in-
creased sensitivity to the hypercalciuric action of dietary 
protein has been described [61], and balance studies in-
dicate that, at any given level of net intestinal absorption 
of calcium, negative calcium balance is clearly more fre-
quent in stone patients with IH than in normal people 
[3]. Therefore, it is not surprising that several studies 
have demonstrated decreased bone mineral density in 
calcium stone formers with 1H [4, 7, 21, 31, 43, 44). 
Whereas studies in the United States usually were per-
formed in patients adhering to a low calcium diet, at 
least two European studies clearly indicate that bone 
mineral density is lower in stone formers who have been 
adhering to a low calcium diet for several years than in 
those who have not been compliant with such a regimen 
[21, 31). 
Low calcium diet: conclusions 
Altogether, available data clearly indicate that a low 
calcium diet as a treatment for idiopathic calcium 
nephrolithiasis should be abandoned, because it may in-
duce negative calcium balance. Since many patients ap-
pear very reluctant to change their long-standing dietary 
habits, they should carefully be advised on a diet moder-
ately restricted in animal flesh protein and sodium which 
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contains 800 mg (20 mmol) calcium from dairy products 
per day, provided that oxalate intake is not exceedingly 
high (see following paragraphs). Compliance with this 
regimen should be assessed by repeatedly measuring uri-
nary excretion rates of calcium as well as of urea and 
sodium. Together with simultaneous calculations of cal-
cium intake from diet questionnaires, these data can help 
to get an idea of the patients' calcium balance. 
Hyperoxaluria 
Increased intestinal oxalate absorption and low 
calcium diet 
There is yet another reason why a low calcium diet 
may be contra-indicated in stone formers with IH. Re-
cently, Curhan et al. [16] published a large prospective 
trial indicating that de novo stone formation occurs at 
increasing rates with decreasing daily calcium con-
swnption. Although not proven by this study, the lack 
of sufficient oxalate binding by the reduced amount of 
calcium available in the intestinal lumen must have in-
creased oxalate absorption and thus urinary oxalate ex-
cretion [55, 58]. Indeed, a recent study of our own 
group [35] demonstrated that 6 healthy subjects ingesting 
2220 mg oxalate/day (about 20-times the amount usually 
ingested) only became hyperoxaluric (695 ± 135 mmol/ 
day) when the diet contained 1200 mg of calcium per 
day, but not when calcium content of the otherwise un-
changed diet was increased to 3840 mg/day (279 ± 48 
mmol/day, p = 0.028). On the latter diet, urinary cal-
cium excretion rate amounted to 7.96 ± 0.93 mmol/day, 
compared to 3.36 ± 0.54 mmol/day on the diet contain-
ing 1200 mg of calcium per day (p = 0.028). How-
ever, urinary calcium oxalate supersaturation, calculated 
by using the index proposed by Tiselius [59], even tend-
ed to be lower on the calcium-rich diet (0.27 ± 0.08) 
than on a normal calcium intake (0.44 ± 0.10, not 
significant). 
In a recent study, Lemann et al. [40] found that 
body size is the more important determinant of urinary 
oxalate excretion than calcium intake among healthy 
adults, possibly because endogenous oxalate synthesis 
changes with lean body mass. However, while we stud-
ied subjects whose intakes of animal flesh protein and 
calcium, both known to affect urinary oxalate excretion 
[46, 55, 58] , were strictly controlled, Lemann et al. [40] 
studied subjects on free-choice diet in whom intakes of 
protein and calcium, assessed by a semiquantitative 
questionnaire, widely varied between 27 and 207 g/day 
and 6.2 and 65.6 mmol/day, respectively. In these 
healthy volunteers, increasing calcium intake only ap-
peared to affect urinary oxalate excretion up to the range 
of 15-20 mmol/day, presumably by limiting intestinal 
absorption of dietary oxalate [ 40]. 
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In stone formers on a low calcium diet, secondary 
increases in urinary oxalate have been observed by sev-
eral authors [reviewed in 58] . Thus, secondary hyper-
oxaluria most likely accounts for high stone recurrence 
rates in patients on a low calcium diet [39] . In addition, 
stone formers with calcitriol-mediated hyperabsorption 
of calcium may even become hyperoxaluric while calci-
um intake is normal: since less calcium is left behind 
more distally in the gut, more oxalate is freely available 
for absorption. Indeed, Giannini et al. [22] found a pos-
itive correlation between urinary oxalate excretion rates 
and serum calcitriol levels. Finally, patients with intesti-
nal malabsorption due to inflammatory bowel disease 
with or without bowel resection or after jejunoileal by-
pass surgery also may exhibit secondary hyperoxaluria 
even when intake of calcium is normal [reviewed in 58]. 
This emphasizes the importance of sufficient unbound 
calcium present in the intestinal lumeu relative to the 
amount of oxalate provided with a specific diet. 
Increased endogenous production of oxalate 
Normally, only 10-15% of urinary oxalate is de-
rived from the diet, the remainder coming from endoge-
nous production [55, 58] . On one hand, ascorbic acid 
is metabolized to oxalate; recent studies, however, sug-
gest that up to 4 g of ascorbic acid may be daily ingest-
ed without significantly increasing urinary oxalate [re-
viewed in 58]. On the other hand, positive correlations 
between oxalate and urinary markers of protein intake 
have been observed by others [58] as well as by our-
selves (unpublished). The same correlations have been 
found for glycolate, a metabolic precursor of oxalate. 
Robertson [ 46] has emphasized that overconsumption of 
animal flesh protein, as often the case in patients ad-
hering to a low calcium diet (see previous paragraphs), 
increases the metabolic production of oxalate from pre-
cursors such as hydroxyproline and tryptophan. Under 
these circumstances, mild hyperoxaluria, arbitrarily de-
fined as a urinary oxalate excretion rate below 1.0 
mmol/day [58] , may ensue. The term "mild metabolic 
hyperoxaluria" originally has been used to describe a 
subset of recurrent calcium oxalate stone formers with 
mildly elevated urinary oxalate and glycolate excretions 
in whom pyridoxine therapy sometimes caused a com-
plete remission [23]. It remains to be seen whether or 
not "mild metabolic hyperoxaluria" represents an incom-
plete form of primary hyperoxaluria [58]. 
In some patients, endogenous oxalate overproduction 
may persist although there is no evidence for animal 
protein overconsumption, due to a lack of pyridoxine or 
an impairment of conversion of pyridoxine to pyridoxal-
5' -phosphate [17]. As a result, glyoxylate, the immedi-
ate precursor of oxalate, is not sufficiently converted to 
glycine, whereby more glycolate and oxalate are being 
Low calcium diet in calcium nephrolithiasis 
Table 1. Causes of hyperoxaluria. Bold letters: most frequently encountered causes. 
Non-metabolic (enteric) hyperoxaluria 
U0x x V > UGlyc X V 
• low calcium diet / calcium binders 
• intestinal malabsorption 
• excessive intake of oxalate-rich foods 
Mild metabolic hyperoxaluria 
U0x x V < UGlyc x V 
• animal protein overconsumption 
• pyridoxine deficiency / I conversion 
pyridoxine - pyridoxal-5'-phosphate. 
U0 x: urinary oxalate; UGlyc: urinary glycolate; V: urine volume/ day 
Stone disease 
"Bad" dietary habits 
Figure 2. The "powder keg and tinderbox theory,• explaining the "idiopathic" formation of calcium oxalate renal 
stones [adapted from ref. 36]. For details, see text. 
formed [45) . Only for such specific cases, but certainly 
not for the general calcium oxalate stone former with 
mild hyperoxaluria, a therapeutic trial of pyridoxine 
supplements appears to be warranted [58). 
Summary 
Our first diagnostic approach to patients with cal-
cium nephrolithiasis and mild hyperoxaluria (usually < 
1000 µmol/day) always consists of establishing the meta-
bolic or non-metabolic origin of hyperoxaluria. As out-
lined in Table 1, this is based on measurements of uri-
nary glycolate. 
Idiopathic Calcium Nephrolithiasis: 
Only due to "Bad Eating Habits"? 
Epidemiologically, there is no doubt that high con-
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sumption of meat protein is associated with increased 
risk of stone formation [46) . However, such "bad eating 
habits," despite that they induce hypercalciuria and hy-
peroxaluria as well as hyperuricosuria and hypocitraturia 
[36), do not automatically lead to calcium renal stone 
formation, and many non-stone formers are very likely 
to have them as well [36). As summarized in Figure 2, 
it is only the combination of a powder keg, i.e., under-
lying (inherited or acquired) abnormalities, and a tin-
derbox, i.e., "bad eating habits," that finally leads to 
an explosion, i.e., renal stone formation [36) . 
One of the underlying abnormalities which appears 
to be of utmost relevance for stone formation has been 
described in severely recurrent calcium renal stone for-
mers by Robertson et al. [48): under identical conditions 
of oral oxalate loading, urines of patients with acceler-
ated calcium nephrolithiasis contained larger crystals 
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than urines of healthy controls, and often these crystals 
were fused into very large polycrystalline aggregates. 
The formation of large particles by means of crystal ag-
gregation appears to be the major element which distin-
guishes recurrent calcium stone formers from healthy 
people [29). Studies with dialyzed [30] as well as with 
whole human urine [18] clearly suggest that the major 
modifiers of crystal aggregation are urinary macromol-
ecules. Many macromolecules, most of them glycopro-
teins or glycosaminoglycans, are present in human urine 
as well as in renal stones [50], and it has been recog-
nized that the functional properties of at least some mac-
romolecules are affected by the physico-chemical com-
position of urine, especially by free calcium ions [9]. 
For example, several studies have demonstrated that 
the most abundant urinary macromolecule, Tamm-Hors-
fall glycoprotein (THP), may be an important inhibitor 
of calcium oxalate crystallization [reviewed in 27]. 
However, THP effects largely depend on physico-chemi-
cal conditions: upon increasing osmolality [25] or ionic 
strength [30, 52] as well as the concentrations of hydro-
gen [30] and calcium ions [32] or the concentrations of 
THP itself [32, 52] within physiologic urinary limits, 
THP molecules progressively lose their inhibitory activi-
ty. This is due to conformational changes of THP mole-
cules which appear to be more pronounced in structural-
ly altered THPs of some severely recurrent calcium 
stone formers [reviewed in 27]. When exposed to phys-
iologic concentrations of calcium ions, such abnormal 
THP molecules lose inappropriately more of their inhibi-
tory activity than THPs from healthy controls, and stone 
former THPs at 40 mg/1 actually become promoters of 
calcium oxalate crystal aggregation [32). As soon as the 
effect of free calcium ions on THP molecules is antago-
nized by chelate formation with citrate, stone former 
THPs again inhibit calcium oxalate crystal aggregation 
[32]. 
These findings confirm that functional properties of 
macromolecules in urine may be strongly affected by 
free calcium ions [9] and thus by the presence of hyper-
calciuria. They also emphasize the importance of suffi-
cient urinary citrate concentrations for the activity of 
some macromolecular inhibitors [60] and thereby once 
again confirm that hypocitraturia is an important risk 
factor for calcium nephrolithiasis. Regarding recurrent 
renal stone formation, one has to conclude that it is only 
by the interplay of "bad eating habits" (tinderbox) and 
additional underlying abnormalities (powder keg) that 
people become highly active renal stone formers . 
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Discussion with Reviewers 
G.C. Curhan: The title of the paper is "Low calcium 
diet in hypercalciuric calcium nephrolithiasis." Over 
50 % of patients who form calcium stones are not hyper-
calciuric. Are your recommendations on calcium and 
animal protein intake applicable to patients with calcium 
nephrolithiasis but who are not hypercalciuric? 
Authors: Yes, they are. Reducing protein intake to 0. 8-
1.0 g/kg of body weight and consuming 800 mg of 
calcium from dairy products are not specific measures 
for patients with calcium nephrolithiasis, but rather part 
of a well-equilibrated "common sense-diet." In addition, 
our own experience (unpublished data) requires that high 
fluid intake is even more emphasized in normocalciuric 
calcium stone formers, since they usually have lower 
urine volumes than hypercalciurics. 
G.C. Curhan: As the urinary calcium concentration al-
ways exceeds that of oxalate, is there any maximum 
amount of calcium that can be ingested without increas-
ing the risk of crystal formation? 
Author: As demonstrated by the studies of Robertson 
et al., the volume of crystals precipitated from urines 
[49] as well as the severity of stone disease [47] do not 
depend on urinary calcium, but strongly increase with 
increasing urinary oxalate concentrations. Therefore, 
one might argue that very high urinary calcium concen-
trations would be tolerated without any further conse-
quences for stone formation. On the other hand, in-
creasing urinary calcium concentrations might change 
the functional properties of macromolecular inhibitors 
and turn them into crystallization promoters, as demon-
strated for Tamm-Horsfall glycoprotein [32]. The 
amount of calcium that can be consumed without any 
risk for stone formation also depends on the amounts of 
Low calcium diet in calcium nephrolithiasis 
oxalate or phosphate which are simultaneously ingested 
and will co-precipitate with calcium in the intestinal 
lumen. In our preliminary study [35], where 2220 mg 
of oxalate were ingested per day, calcium intake was as 
high as 3840 mg/day; this was tolerated without any 
problem, and urinary calcium oxalate supersaturation 
even tended to fall in comparison with the day where the 
same subjects consumed 2220 mg of oxalate together 
with 1200 mg of calcium. 
G.C. Corban: Calcium supplements, typically in the 
form of calcium carbonate, are used by many individuals 
for prevention of osteoporosis. Can calcium supple-
ments replace dairy or other dietary sources of calcium? 
Author: According to Sheikh et al. [52], intestinal cal-
cium absorption from calcium salts ( carbonate, acetate, 
lactate, gluconate and citrate) and from whole milk is 
similar. When comparing the availability of calcium for 
absorption from dairy foods (whole milk, skim milk and 
Cheddar cheese), non-dairy foods (collards, oatmeal) 
and calcium salts (calcium gluconate and calcium car-
bonate), Spencer and Norris [55] did not find any differ-
ence between the 7 sources of calcium. Therefore, cal-
cium supplements certainly may (and often have to) re-
place dietary sources of calcium. 
R.A.L. Sutton: Not all studies report elevated calcitriol 
levels in idiopathic hypercalciuria. What does the author 
consider to be the relative importance of increased calci-
triol production versus hypersensitivity to calcitriol in 
the production of idiopathic hypercalciuria? 
Author: So far, direct evidence for calcitriol hypersen-
sitivity has only been provided in rats with absorptive 
hypercalciuria whose calvariae were hypersensitive to 
calcitriol-induced bone resorption in vitro [56]. In 
humans, hypersensitivity to calcitriol remains rather spe-
culative, whereas elevated calcitriol levels in patients 
with IH have repeatedly been found [reviewed in 28]. 
When studying subjects on a very low calcium diet, Coe 
et al. [14] found normal calcitriol levels; however, they 
were inappropriately elevated with respect to the rela-
tively low PTH levels. Very similar findings were ob-
tained in hypercalciuric calcium stone formers on free-
choice diet [31], indicating that calcitriol and PTH are 
in mutual imbalance in patients with 1H [34] . In 
humans, it is still hypothetical that this might indicate 
hypersensitivity to calcitriol [9]. 
R.A.L. Sutton: Would not PTH suppression lead to 
transient hypercalciuria, followed by a return to the 
base-line urinary calcium level accompanied by a lower 
serum ultra-filtrable calcium, i.e., to increased fractional 
rather than absolute urinary calcium excretion? In other 
words, is PTH suppression causative with respect to 
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hypercalciuria? 
Author: Previous studies by Broadus et al. [11] as well 
as by ourselves [31] demonstrated a significant negative 
correlation between fasting urinary calcium excretion 
and cyclic AMP or intact PTH, respectively, indicating 
that PTH suppression indeed could be causative with re-
spect to IH. Considering a patient consuming constant 
amounts of protein, salt and calcium, one certainly 
would predict that any suppression of PTH secretion 
would lead to hypercalciuria, followed by a fall in blood 
ionized calcium with a subsequent increase in PTH se-
cretion, whereby hypercalciuria would be transient. 
However, we often see stone patients in whom hypercal-
ciuria persists, even if their calcium intake is very low, 
and many of them exhibit overconsumption of animal 
flesh protein and/or salt. The relatively low-normal 
levels of intact PTH that we find in these patients on low 
calcium/high protein diet can be explained by their in-
appropriately high calcitriol levels [31, 33]. This ap-
pears to indicate that low calcium intake, especially 
when combined with high protein consumption, inappro-
priately stimulates calcitriol production more than it in-
creases PTH secretion in patients with IH, leading to the 
observed mutual imbalance of the 2 hormones [34] . 
R.A.L. Sutton: In view of the adaptation to low cal-
cium intakes, would monitoring of the urinary calcium 
really be of value in checking the patients compliance 
with an adequate calcium intake? 
Author: In order to get information on the patient's 
intakes of protein, salt and calcium, we measure urinary 
excretion rates of urea, salt and calcium. By consider-
ing these measurements together with the patient's diet 
history, we certainly can get some (semi-quantitative) 
idea of the patient's compliance with our dietary advice 
and approximately of his calcium balance. For instance, 
we recently saw a 24-year old man, body weight (BW) 
84 kg, with recurrent calcium stone disease whose daily 
protein consumption, based on urinary urea excretion, 
amounted to 138 g or 1.64 g/kg BW. He denied con-
suming any dairy products; thus, his daily calcium in-
take at the time of investigation did not exceed 400 mg. 
If we assume that calcitriol production must have been 
stimulated by the very low calcium intake and that net 
intestinal absorption of calcium could have been as high 
as 50 % , the patient might have absorbed 200 mg of the 
ingested calcium. However, urinary calcium excretion 
rate was 377 mg/day, thus, the patient was hypercalciu-
ric. At least at the time of investigation, he must have 
been in negative calcium balance. 
G.A. Rose: In any discussion of the treatment of renal 
stones, there should be a reference to the value of high 
water intake. Why has this been omitted? 
B. Hess 
Author: To discuss the value of high water intake is 
beyond the scope of a pathophysiology-oriented review 
of idiopathic hypercalciuria. Nevertheless, high water 
intake is undoubtedly one of the most important issues 
in the treatment of renal stones. This appears to be 
particularly true with respect to the role of THP in renal 
stone formation. Several studies [25, 30, 32, 51] have 
indicated that THP molecules progressively lose their 
inhibitory activity towards calcium oxalate crystallization 
processes with increasing ionic strength/osmolality of the 
solution or with rising concentrations of THP itself. 
This provides an additional basis for high fluid intake as 
treatment of idiopathic calcium nephrolithiasis. 
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